Lilly will hope that Foundayo continues to dominate and grow over Novo Nordisk in the obesity drug market. Credit: Michael Vi / Shutterstock.com. The US Food and Drug Administration (FDA) has approved Eli Lilly’s orforglipron pill for weight loss, ending Novo Nordisk’s first mover profits in the US after just three months. Oral glucagon-like peptide-1 … Read more
Foundayo, a new obesity pill made by Eli Lilly, was recently approved by the Food and Drug Administration. Eli Lilly hide caption caption letter Eli Lilly The Food and Drug Administration has approved a second GLP-1 pill to treat obesity, this time from drugmaker Eli Lilly. The new pill, Foundayo, is taken once a day … Read more
Item 1 of 2 The Zepbound injection pen, Eli Lilly’s weight loss drug, is displayed in New York City, U.S., December 11, 2023. REUTERS/Brendan McDermid/ File Photo [1/2]Zepbound syringes, Eli Lilly’s weight loss drug, are displayed in New York City, U.S., December 11, 2023. REUTERS/Brendan McDermid/ File Photo Purchase Licensing RIGHTSopen a new tab April … Read more
If the number on the scale has gone down, it may not be for the reason you want. Most of the time, when you aim to lose weight, you may be looking for fat loss, or reduce excess body fat to change your appearance or improve your health and quality of life, says Dympna Gallagher, … Read more
4 minutes to read If it seems like new medications for weight loss are coming out at a fast rate, that’s because. The first GLP-1 oral pills became available earlier this year. Now, a new oral GLP-1 from drug company Eli Lilly—called Foundayo (orforglipron)—has just won FDA approval. Wajahat Mehal, MD, Medical Director of the … Read more
As more people live longer with HIV, managing other health conditions is even more important. Research presented at the recent Conference on Retroviruses and Opportunistic Infections (CROI 2026) in Denver covers a wide range of issues – from new obesity drugs and cardiovascular risks to transplant outcomes and the use of stimulant drugs. Here are … Read more
The US Food and Drug Administration on Wednesday approved a second GLP-1 pill for weight loss, adding another option to its rapidly growing arsenal of obesity therapies. The orforglipron pill, called Foundayo, is made by Eli Lilly, which also sells the GLP-1 drugs Zepbound for obesity and Mounjaro for diabetes. It is given as a … Read more
The US Food and Drug Administration has approved it Eli LillyPills GLP-1 ‘s, said the company, a major milestone for the Indianapolis-based drugmaker and one that will test the market for new weight loss medications. Lilly said the once-daily pill, Foundayo, will begin shipping from LillyDirect’s direct-to-consumer platform on Monday and will be available in … Read more
In an environmental chemist in Gurugram, “Wegovy ya Ozempic hey what??” [Do you have Wegovy or Ozempic?] has become a daily refrain. Since semaglutide lost patent protection in India on March 20, and dozens of low-cost generics flooded the market, retail pharmacies have increasingly become the first point of contact for weight loss hopefuls, often … Read more
BEIJING, April 01, 2026–(BUSINESS WIRE)–Biocytogen Pharmaceuticals (Beijing) Co., Ltd. Pharmacy; HKEX: 00460). Under the agreement, both parties will combine Biocytogen’s fully human antibody discovery platform with Sihuan Pharmaceutical’s extensive capabilities in drug development, manufacturing, and commercialization. The collaboration will focus on advancing innovative therapies in multiple disease areas, including weight loss, leveraging complementary strengths to … Read more